VESTIS CORP (VSTS) Stock News

USA - New York Stock Exchange - NYSE:VSTS - US29430C1027 - Common Stock

6.08 USD

+0.55 (+9.95%)

Last: 11/21/2025, 8:05:01 PM

6.05 USD

-0.03 (-0.49%)

After Hours: 11/21/2025, 8:05:01 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

VSTS Latest News, Press Relases and Analysis

All

Press Releases

4 days ago - By: Zacks Investment Research - Mentions: POWL

Powell Industries (POWL) Tops Q4 Earnings and Revenue Estimates

5 days ago - By: Vestis

Vestis Announces Date for Fiscal Fourth Quarter and Full Year 2025 Results Conference Call and Webcast

9 days ago - By: Zacks Investment Research - Mentions: RSSS

Research Solutions Inc. (RSSS) Meets Q1 Earnings Estimates

15 days ago - By: Kahn Swick & Foti, LLC

Vestis Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Vestis Corporation - VSTS

16 days ago - By: Zacks Investment Research - Mentions: KRT

Karat Packing (KRT) Q3 Earnings Miss Estimates

17 days ago - By: Zacks Investment Research - Mentions: AIN

Albany International (AIN) Q3 Earnings Surpass Estimates

a month ago - By: Halper Sadeh LLP

HALPER SADEH LLC ENCOURAGES VESTIS CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

a month ago - By: Kahn Swick & Foti, LLC

Vestis Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Vestis Corporation - VSTS

a month ago - By: Halper Sadeh LLC

Halper Sadeh LLC Encourages Vestis Corporation Shareholders to Contact the Firm to Discuss Their Rights

a month ago - By: Bragar Eagel & Squire

VESTIS INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Vestis Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

a month ago - By: Grabar Law Office - Mentions: AMLX HUM FIVE

Attention Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX); Humana Inc. (NYSE: HUM); Five Below, Inc. (NASDAQ: FIVE); and Vestis Corp. (NYSE: VSTS): Grabar Law Office is Investigating Claims on Your Behalf

2 months ago - By: Bragar Eagel & Squire

VESTIS ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Vestis Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

2 months ago - By: Grabar Law Office - Mentions: HUM AMLX UNCY

Attention Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX); Humana Inc. (NYSE: HUM); Unicycive Therapeutics, Inc. (NASDAQ: UNCY); and Vestis Corp. (NYSE: VSTS): Grabar Law Office is Investigating Claims on Your Behalf

2 months ago - By: Vestis Corporation

Vestis Announces Key Leadership Appointments

2 months ago - By: Grabar Law Office - Mentions: HUM JSPR UNCY

Important Notice to Long-Term Shareholders of Humana Inc. (NYSE: HUM); Jasper Therapeutics, Inc. (NASDAQ: JSPR); Unicycive Therapeutics, Inc. (NASDAQ: UNCY); and Vestis Corp. (NYSE: VSTS): Grabar Law Office is Investigating Claims on Your Behalf

2 months ago - By: Grabar Law Office - Mentions: FLR HUM MSS

Important Notice to Long-Term Shareholders of Fluor Corporation (NYSE: FLR); Humana Inc. (NYSE: HUM); Maison Solutions Inc. (NASDAQ: MSS); and Vestis Corp. (NYSE: VSTS): Grabar Law Office is Investigating Claims on Your Behalf

2 months ago - By: Grabar Law Office - Mentions: ELV HUM MSS

Important Notice to Long-Term Shareholders of Elevance Health, Inc. (NYSE: ELV); Humana Inc. (NYSE: HUM); Maison Solutions Inc. (NASDAQ: MSS); and Vestis Corp. (NYSE: VSTS): Grabar Law Office is Investigating Claims on Your Behalf

2 months ago - By: Kuehn Law, PLLC

Kuehn Law Encourages Investors of Vestis Corporation to Contact Law Firm

3 months ago - By: Vestis Corporation

Vestis Receives 2025 Supplier Legacy Award from Premier, Inc.

3 months ago - By: Bragar Eagel & Squire

VESTIS INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Vestis Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm